| Product Name | NebuSelect™ Recombinant Cynomolgus BSPII, His-tag |
|---|---|
| Catalog Number | NBL-241724 |
| Alias/Synonyms | BSPII |
| Appearance | see COA |
| Molecule Weight | Phe17-Gln318 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | A0A2K5UM27 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241724-100ug | 100ug | Inquire | Inquire | |
| NBL-241724-1mg | 1mg | Inquire | Inquire | |
| NBL-241724-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus BSPII, His-tag
Catalog#:
NBL-241724
Description:
NebuSelect™ Recombinant Cynomolgus BSPII, His-tag(Cat#NBL-241724) is expressed in HEK293 with His tag at the C-Terminus.It contains Phe17-Gln318.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 34.63 kDa. Due to glycosylation, the protein migrates to 60-80 kDa based on Bis-Tris PAGE result.
Target Name:
BSPII
Target Information:
IBSP (Integrin Binding Sialoprotein) is a Protein Coding gene. Diseases associated with IBSP include Fibrous Dysplasia and Chondromalacia. Among its related pathways are Degradation of the extracellular matrix and Cytoskeletal Signaling.The protein encoded by this gene is a major structural protein of the bone matrix. It constitutes approximately 12% of the noncollagenous proteins in human bone and is synthesized by skeletal-associated cell types, including hypertrophic chondrocytes, osteoblasts, osteocytes, and osteoclasts.
Amino Acid Sequence:
Phe17-Gln318
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.